NCT07011719 2026-04-01
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Arcus Biosciences, Inc.
Phase 3 Recruiting
Arcus Biosciences, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
University Hospital, Linkoeping
Sun Yat-sen University
Tampere University Hospital
Gustave Roussy, Cancer Campus, Grand Paris
Samsung Medical Center